{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:52:08Z","timestamp":1789509128504,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T00:00:00Z","timestamp":1407110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,6,4]]},"DOI":"10.1038\/onc.2014.236","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T06:08:11Z","timestamp":1407132491000},"page":"3076-3084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["Regulation of tumor cell migration and invasion by the H19\/let-7 axis is antagonized by metformin-induced DNA methylation"],"prefix":"10.1038","volume":"34","author":[{"given":"L","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Santin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,4]]},"reference":[{"key":"BFonc2014236_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/bies.200900170","volume":"32","author":"A Gabory","year":"2010","unstructured":"Gabory A, Jammes H, Dandolo L . The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010; 32: 473\u2013480.","journal-title":"Bioessays"},{"key":"BFonc2014236_CR2","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3390\/ijms14024298","volume":"14","author":"I Matouk","year":"2013","unstructured":"Matouk I, Raveh E, Ohana P, Lail RA, Gershtain E, Gilon M et al. The increasing complexity of the oncofetal h19 gene locus: functional dissection and therapeutic intervention. Intl J Mol Sci 2013; 14: 4298\u20134316.","journal-title":"Intl J Mol Sci"},{"key":"BFonc2014236_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0301-2115(98)00275-9","volume":"85","author":"V Tanos","year":"1999","unstructured":"Tanos V, Prus D, Ayesh S, Weinstein D, Tykocinski ML, De-Groot N et al. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999; 85: 7\u201311.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"BFonc2014236_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1048-891x.2004.014314.x","volume":"14","author":"V Tanos","year":"2004","unstructured":"Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A . H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Intl J Gynecol Cancer 2004; 14: 521\u2013525.","journal-title":"Intl J Gynecol Cancer"},{"key":"BFonc2014236_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/carcin\/bgp181","volume":"31","author":"WP Tsang","year":"2010","unstructured":"Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ et al. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis 2010; 31: 350\u2013358.","journal-title":"Carcinogenesis"},{"key":"BFonc2014236_CR6","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pone.0000845","volume":"2","author":"IJ Matouk","year":"2007","unstructured":"Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A et al. The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2007; 2: e845.","journal-title":"PLoS ONE"},{"key":"BFonc2014236_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2013.01.033","volume":"333","author":"M Luo","year":"2013","unstructured":"Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J . Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett 2013; 333: 213\u2013221.","journal-title":"Cancer Lett"},{"key":"BFonc2014236_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/ng.2654","volume":"45","author":"G Wang","year":"2013","unstructured":"Wang G, Lunardi A, Zhang J, Chen Z, Ala U, Webster KA et al. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat Genet 2013; 45: 739\u2013746.","journal-title":"Nat Genet"},{"key":"BFonc2014236_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/365764a0","volume":"365","author":"Y Hao","year":"1993","unstructured":"Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B . Tumour-suppressor activity of H19 RNA. Nature 1993; 365: 764\u2013767.","journal-title":"Nature"},{"key":"BFonc2014236_CR10","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1073\/pnas.0801540105","volume":"105","author":"T Yoshimizu","year":"2008","unstructured":"Yoshimizu T, Miroglio A, Ripoche MA, Gabory A, Vernucci M, Riccio A et al. The H19 locus acts in vivo as a tumor suppressor. Proc Natl Acad Sci USA 2008; 105: 12417\u201312422.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014236_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/carcin\/bgs381","volume":"34","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yang F, Yuan J-h, Yuan S-x, Zhou W-p, Huo X-s et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 2013; 34: 577\u2013586.","journal-title":"Carcinogenesis"},{"key":"BFonc2014236_CR12","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/onc.2011.408","volume":"31","author":"D Fanale","year":"2011","unstructured":"Fanale D, Amodeo V, Corsini LR, Rizzo S, Bazan V, Russo A . Breast cancer genome-wide association studies: there is strength in numbers. Oncogene 2011; 31: 2121\u20132128.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR13","first-page":"12","volume":"133","author":"M Riaz","year":"2011","unstructured":"Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, Groenewoud A et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res Treat 2011; 133: 12.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014236_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molcel.2013.08.027","volume":"52","author":"AN Kallen","year":"2013","unstructured":"Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101\u2013112.","journal-title":"Mol Cell"},{"key":"BFonc2014236_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","volume":"18","author":"S Roush","year":"2008","unstructured":"Roush S, Slack FJ . The let-7 family of microRNAs. Trends Cell Biol 2008; 18: 505\u2013516.","journal-title":"Trends Cell Biol"},{"key":"BFonc2014236_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nsmb.2296","volume":"19","author":"MR Fabian","year":"2012","unstructured":"Fabian MR, Sonenberg N . The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586\u2013593.","journal-title":"Nat Struct Mol Biol"},{"key":"BFonc2014236_CR17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11033-011-0854-7","volume":"39","author":"Q Liu","year":"2012","unstructured":"Liu Q, Lv G-D, Qin X, Gen Y-H, Zheng S-T, Liu T et al. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol Biol Rep 2012; 39: 1239\u20131246.","journal-title":"Mol Biol Rep"},{"key":"BFonc2014236_CR18","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1158\/0008-5472.CAN-11-1322","volume":"71","author":"P Qian","year":"2011","unstructured":"Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 2011; 71: 6463\u20136474.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR19","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1038\/emboj.2011.312","volume":"30","author":"J Yun","year":"2011","unstructured":"Yun J, Frankenberger CA, Kuo W-L, Boelens MC, Eves EM, Cheng N et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 2011; 30: 4500\u20134514.","journal-title":"EMBO J"},{"key":"BFonc2014236_CR20","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1038\/onc.2013.385","volume":"33","author":"X Fu","year":"2014","unstructured":"Fu X, Meng Z, Linag W, Tian Y, Wang X, Han W et al. miR-26a enhances miRNA biogenesis by targeting Lin28B and Zcchc11 to suppress tumor growth and metastasis. Oncogene 2014; 33: 4296\u20134306.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","volume":"342","author":"B Zhao","year":"2014","unstructured":"Zhao B, Han H, Chen J, Zhang Z, Li S, Fang F et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 2014; 342: 43\u201351.","journal-title":"Cancer Lett"},{"key":"BFonc2014236_CR22","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1158\/0008-5472.CAN-06-0037","volume":"66","author":"D Barsyte-Lovejoy","year":"2006","unstructured":"Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 2006; 66: 5330\u20135337.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","volume":"21","author":"YS Lee","year":"2007","unstructured":"Lee YS, Dutta A . The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21: 1025\u20131030.","journal-title":"Genes Dev"},{"key":"BFonc2014236_CR24","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1126\/science.1137999","volume":"315","author":"C Mayr","year":"2007","unstructured":"Mayr C, Hemann MT, Bartel DP . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576\u20131579.","journal-title":"Science"},{"key":"BFonc2014236_CR25","doi-asserted-by":"publisher","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","volume":"67","author":"VB Sampson","year":"2007","unstructured":"Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 2007; 67: 9762\u20139770.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","volume":"147","author":"H Zhu","year":"2011","unstructured":"Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS et al. The Lin28\/let-7 axis regulates glucose metabolism. Cell 2011; 147: 81\u201394.","journal-title":"Cell"},{"key":"BFonc2014236_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature11061","volume":"485","author":"H Toledano","year":"2012","unstructured":"Toledano H, D'Alterio C, Czech B, Levine E, Jones DL . The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche. Nature 2012; 485: 605\u2013610.","journal-title":"Nature"},{"key":"BFonc2014236_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/emboj.2008.294","volume":"28","author":"S Dangi-Garimella","year":"2009","unstructured":"Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009; 28: 347\u2013358.","journal-title":"EMBO J"},{"key":"BFonc2014236_CR29","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","volume":"73","author":"A Morishita","year":"2013","unstructured":"Morishita A, Zaidi MR, Mitoro A, Sankarasharma D, Szabolcs M, Okada Y et al. HMGA2 is a driver of tumor metastasis. Cancer Res 2013; 73: 4289\u20134299.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR30","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1038\/onc.2012.573","volume":"32","author":"L Guo","year":"2013","unstructured":"Guo L, Chen C, Shi M, Wang F, Chen X, Diao D et al. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene 2013; 32: 5272\u20135282.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR31","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1073\/pnas.1305172110","volume":"110","author":"M Sun","year":"2013","unstructured":"Sun M, Song C-X, Huang H, Frankenberger CA, Sankarasharma D, Gomes S et al. HMGA2\/TET1\/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc Natl Acad Sci USA 2013; 110: 9920\u20139925.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014236_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tcb.2012.06.001","volume":"22","author":"JE Thornton","year":"2012","unstructured":"Thornton JE, Gregory RI . How does Lin28 let-7 control development and disease? Trends Cell Biol 2012; 22: 474\u2013482.","journal-title":"Trends Cell Biol"},{"key":"BFonc2014236_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/wrna.1112","volume":"3","author":"Y Huang","year":"2012","unstructured":"Huang Y . A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdiscip Rev RNA 2012; 3: 483\u2013494 29.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"BFonc2014236_CR34","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","volume":"70","author":"JL Bell","year":"2013","unstructured":"Bell JL, Wachter K, Muhleck B, Pazaitis N, Kohn M, Lederer M et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 2013; 70: 2657\u20132675.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2014236_CR35","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/hep.22459","volume":"48","author":"Y-M Jeng","year":"2008","unstructured":"Jeng Y-M, Chang C-C, Hu F-C, Chou H-YE, Kao H-L, Wang T-H et al. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008; 48: 1118\u20131127.","journal-title":"Hepatology"},{"key":"BFonc2014236_CR36","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.humpath.2009.05.005","volume":"40","author":"O Walter","year":"2009","unstructured":"Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A . IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Hum Pathol 2009; 40: 1528\u20131533.","journal-title":"Hum Pathol"},{"key":"BFonc2014236_CR37","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1038\/onc.2011.620","volume":"31","author":"S Samanta","year":"2012","unstructured":"Samanta S, Sharma VM, Khan A, Mercurio AM . Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer. Oncogene 2012; 31: 4689\u20134697.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR38","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/sj.emboj.7601039","volume":"25","author":"J Vikesaa","year":"2006","unstructured":"Vikesaa J, Hansen TVO, Jonson L, Borup R, Wewer UM, Christiansen J et al. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J 2006; 25: 1456\u20131468.","journal-title":"EMBO J"},{"key":"BFonc2014236_CR39","doi-asserted-by":"publisher","first-page":"25882","DOI":"10.1074\/jbc.M110.178012","volume":"286","author":"R Suvasini","year":"2011","unstructured":"Suvasini R, Shruti B, Thota B, Shinde SV, Friedmann-Morvinski D, Nawaz Z et al. Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase\/mitogen-activated protein kinase (PI3K\/MAPK) pathways by modulating IGF-2. J Biol Chem 2011; 286: 25882\u201325890.","journal-title":"J Biol Chem"},{"key":"BFonc2014236_CR40","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1093\/carcin\/bgn187","volume":"29","author":"S Tokumaru","year":"2008","unstructured":"Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T . let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29: 2073\u20132077.","journal-title":"Carcinogenesis"},{"key":"BFonc2014236_CR41","doi-asserted-by":"publisher","first-page":"14879","DOI":"10.1073\/pnas.0803230105","volume":"105","author":"JJ Forman","year":"2008","unstructured":"Forman JJ, Legesse-Miller A, Coller HA . A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci USA 2008; 105: 14879\u201314884.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014236_CR42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG . Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009; 119: 1429\u20131437.","journal-title":"J Clin Invest"},{"key":"BFonc2014236_CR43","first-page":"1385","volume":"8","author":"JM Green","year":"2009","unstructured":"Green JM, Alvero AB, Kohen F, Mor G . Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells. Mol Cancer Ther 2009; 8: 1385\u20131393.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014236_CR44","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1073\/pnas.1222577110","volume":"110","author":"S Zhao","year":"2013","unstructured":"Zhao S, Choi M, Overton JD, Bellone S, Roque DM, Cocco E et al. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci USA 2013; 110: 2916\u20132921.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014236_CR45","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1172\/JCI67232","volume":"123","author":"M Pollak","year":"2013","unstructured":"Pollak M . Potential applications for biguanides in oncology. J Clin Invest 2013; 123: 3693\u20133700.","journal-title":"J Clin Invest"},{"key":"BFonc2014236_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1158\/1940-6207.CAPR-12-0026","volume":"5","author":"F Bednar","year":"2012","unstructured":"Bednar F, Simeone DM . Metformin and cancer stem cells: old drug, new targets. Cancer Prev Res (Phila) 2012; 5: 351\u2013354.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFonc2014236_CR47","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","volume":"69","author":"HA Hirsch","year":"2009","unstructured":"Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K . Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009; 69: 7507\u20137511.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-11-0299","volume":"5","author":"B Bao","year":"2012","unstructured":"Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH et al. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res (Phila) 2012; 5: 355\u2013364.","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFonc2014236_CR49","doi-asserted-by":"publisher","first-page":"e63969","DOI":"10.1371\/journal.pone.0063969","volume":"8","author":"S Gou","year":"2013","unstructured":"Gou S, Cui P, Li X, Shi P, Liu T, Wang C . Low concentrations of metformin selectively inhibit CD133+ cell proliferation in pancreatic cancer and have anticancer action. PloS One 2013; 8: e63969.","journal-title":"PloS One"},{"key":"BFonc2014236_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4161\/cc.23050","volume":"12","author":"R Wurth","year":"2013","unstructured":"Wurth R, Pattarozzi A, Gatti M, Bajetto A, Corsaro A, Parodi A et al. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt. Cell Cycle 2013; 12: 145\u2013156.","journal-title":"Cell Cycle"},{"key":"BFonc2014236_CR51","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/or.2012.1890","volume":"28","author":"B Wu","year":"2012","unstructured":"Wu B, Li S, Sheng L, Zhu J, Gu L, Shen H et al. Metformin inhibits the development and metastasis of ovarian cancer. Oncol Rep 2012; 28: 903\u2013908.","journal-title":"Oncol Rep"},{"key":"BFonc2014236_CR52","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1535-7163.MCT-12-1226-T","volume":"12","author":"M Cerezo","year":"2013","unstructured":"Cerezo M, Tichet M, Abbe P, Ohanna M, Lehraiki A, Rouaud F et al. Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner. Mol Cancer Ther 2013; 12: 1605\u20131615.","journal-title":"Mol Cancer Ther"},{"key":"BFonc2014236_CR53","doi-asserted-by":"publisher","first-page":"e61537","DOI":"10.1371\/journal.pone.0061537","volume":"8","author":"R Sarfstein","year":"2013","unstructured":"Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H . Metformin downregulates the insulin\/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners. PLoS ONE 2013; 8: e61537.","journal-title":"PLoS ONE"},{"key":"BFonc2014236_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ng0794-433","volume":"7","author":"MJ Steenman","year":"1994","unstructured":"Steenman MJ, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP . Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 1994; 7: 433\u2013439.","journal-title":"Nat Genet"},{"key":"BFonc2014236_CR55","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1210\/jcem.87.3.8331","volume":"87","author":"Z-H Gao","year":"2002","unstructured":"Gao Z-H, Suppola S, Liu J, Heikkila P, Janne J, Voutilainen R . Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. J Clin Endocrinol Metabol 2002; 87: 1170\u20131176.","journal-title":"J Clin Endocrinol Metabol"},{"key":"BFonc2014236_CR56","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1101\/gad.14.10.1186","volume":"14","author":"M Srivastava","year":"2000","unstructured":"Srivastava M, Hsieh S, Grinberg A, Williams-Simons L, Huang SP, Pfeifer K . H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19. Genes Dev 2000; 14: 1186\u20131195.","journal-title":"Genes Dev"},{"key":"BFonc2014236_CR57","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1158\/0008-5472.CAN-07-2544","volume":"67","author":"L Lu","year":"2007","unstructured":"Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H . Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 2007; 67: 10117\u201310122.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR58","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10549-010-1168-5","volume":"126","author":"L Lu","year":"2011","unstructured":"Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE et al. Let-7a regulation of insulin-like growth factors in breast cancer. Breast Cancer Res Treat 2011; 126: 687\u2013694.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc2014236_CR59","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ijc.28371","volume":"134","author":"Z Tang","year":"2013","unstructured":"Tang Z, Ow GS, Thiery JP, Ivshina AV, Kuznetsov VA . Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma. Int J Cancer 2013; 134: 306\u2013318.","journal-title":"Int J Cancer"},{"key":"BFonc2014236_CR60","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Brule S, Viollet B et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. Cell Metabol 2010; 11: 390\u2013401.","journal-title":"Cell Metabol"},{"key":"BFonc2014236_CR61","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","volume":"71","author":"I Ben Sahra","year":"2011","unstructured":"Ben Sahra I, Regazzetti C, Robert G, Laurent K, Le Marchand-Brustel Y, Auberger P et al. Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1. Cancer Res 2011; 71: 4366\u20134372.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature06640","volume":"452","author":"S Kangaspeska","year":"2008","unstructured":"Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP et al. Transient cyclical methylation of promoter DNA. Nature 2008; 452: 112\u2013115.","journal-title":"Nature"},{"key":"BFonc2014236_CR63","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/npp.2012.125","volume":"38","author":"DR Grayson","year":"2013","unstructured":"Grayson DR, Guidotti A . The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 2013; 38: 138\u2013166.","journal-title":"Neuropsychopharmacology"},{"key":"BFonc2014236_CR64","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1038\/sj.onc.1208662","volume":"24","author":"G Reid","year":"2005","unstructured":"Reid G, Metivier R, Lin C-Y, Denger S, Ibberson D, Ivacevic T et al. Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 2005; 24: 4894\u20134907.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nrc3486","volume":"13","author":"W Timp","year":"2013","unstructured":"Timp W, Feinberg AP . Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nature Rev Cancer 2013; 13: 497\u2013510.","journal-title":"Nature Rev Cancer"},{"key":"BFonc2014236_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","volume":"301","author":"AP Feinberg","year":"1983","unstructured":"Feinberg AP, Vogelstein B . Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89\u201392.","journal-title":"Nature"},{"key":"BFonc2014236_CR67","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1093\/carcin\/bgt307","volume":"34","author":"T Akinyeke","year":"2013","unstructured":"Akinyeke T, Matsumura S, Wang X, Wu Y, Schalfer ED, Saxena A et al. Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis 2013; 34: 2823\u20132832.","journal-title":"Carcinogenesis"},{"key":"BFonc2014236_CR68","first-page":"414","volume":"47","author":"BC Behrens","year":"1987","unstructured":"Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG et al. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res 1987; 47: 414\u2013418.","journal-title":"Cancer Res"},{"key":"BFonc2014236_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/onc.2012.33","volume":"32","author":"G Yin","year":"2013","unstructured":"Yin G, Alvero AB, Craveiro V, Holmberg JC, Fu HH, Montagna MK et al. Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential. Oncogene 2013; 32: 39\u201349.","journal-title":"Oncogene"},{"key":"BFonc2014236_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4161\/cc.20893","volume":"11","author":"C Feng","year":"2012","unstructured":"Feng C, Neumeister V, Ma W, Xu J, Lu L, Bordeaux J et al. Lin28 regulates HER2 and promotes malignancy through multiple mechanisms. Cell Cycle 2012; 11: 13.","journal-title":"Cell Cycle"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014236","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:11:44Z","timestamp":1647879104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,4]]},"references-count":70,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,6,4]]}},"alternative-id":["BFonc2014236"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.236","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,4]]},"assertion":[{"value":"17 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}